Matches in Ghent University Academic Bibliography for { <https://biblio.ugent.be/publication/01GKVJ99HHQBAAX8360QDXFQNG> ?p ?o. }
Showing items 1 to 26 of
26
with 100 items per page.
- 01GKVJ99HHQBAAX8360QDXFQNG classification A1.
- 01GKVJ99HHQBAAX8360QDXFQNG date "2022".
- 01GKVJ99HHQBAAX8360QDXFQNG language "eng".
- 01GKVJ99HHQBAAX8360QDXFQNG type journalArticle.
- 01GKVJ99HHQBAAX8360QDXFQNG hasPart 01GMZMTG126BY8T1BPEGCQXR8P.pdf.
- 01GKVJ99HHQBAAX8360QDXFQNG subject "Biology and Life Sciences".
- 01GKVJ99HHQBAAX8360QDXFQNG doi "10.1016/j.pestbp.2022.105235".
- 01GKVJ99HHQBAAX8360QDXFQNG issn "0048-3575".
- 01GKVJ99HHQBAAX8360QDXFQNG issn "1095-9939".
- 01GKVJ99HHQBAAX8360QDXFQNG volume "188".
- 01GKVJ99HHQBAAX8360QDXFQNG abstract "The two-spotted spider mite, Tetranychus urticae Koch (Acari: Tetranychidae) is the most economically important mite pest in agricultural areas and chemical acaricides are widely used to control T. urticae populations. Cyflumetofen is a recently introduced acaricide that inhibits the mitochondrial electron transport chain at complex II (succinate dehydrogenase, SDH), which represents the most recently developed mode of action for mite control worldwide. In the present study, started upon the launch of cyflumetofen in Turkey, a five-year survey was performed to monitor cyflumetofen susceptibility in 28 T. urticae populations collected from agri-cultural fields across the country. The first resistance case that might cause control failure in practical field conditions was uncovered in 2019, three years after the registration of cyflumetofen. In addition, an extremely resistant population (1722-fold resistance) was also detected towards the end of 2019. Cyflumetofen resistance did not decrease in the laboratory after relaxation of selection pressure for over one year in field-collected populations, suggesting the absence of a fitness cost associated with resistance in these populations. Next to phenotypic resistance, metabolic and physiological mechanisms underlying the decreased susceptibility were also investigated. Synergism assays showed the involvement of P450 monooxygenases in cyflumetofen resis-tance. Downregulation of carboxylesterases as resistance mechanism, is underpinned by the fact that pre-treatment with esterase inhibitor DEF decreased cyflumetofen toxicity in field-collected strains. Furthermore, a novel H258L substitution in the subunit B of complex II was uncovered in a field population. In silico modeling of the new mutation suggested that the mutation might indeed influence toxicity to complex II inhibitors cye-nopyrafen and pyflubumide, but most likely not cyflumetofen. However, further studies are needed to uncover the exact role of this mutation in resistance to this new class of complex II inhibitors.".
- 01GKVJ99HHQBAAX8360QDXFQNG author B3FDA284-798C-11E8-8140-2A9511A95AF2.
- 01GKVJ99HHQBAAX8360QDXFQNG author F5DB1E30-F0ED-11E1-A9DE-61C894A0A6B4.
- 01GKVJ99HHQBAAX8360QDXFQNG author F890AED8-F0ED-11E1-A9DE-61C894A0A6B4.
- 01GKVJ99HHQBAAX8360QDXFQNG author urn:uuid:81c76ca9-8d71-4585-8c3f-1c48dd0041d5.
- 01GKVJ99HHQBAAX8360QDXFQNG author urn:uuid:919954b7-fbfa-4b44-af40-7c2b43427b70.
- 01GKVJ99HHQBAAX8360QDXFQNG author urn:uuid:963905c3-d282-4868-8fde-57225dde2bc3.
- 01GKVJ99HHQBAAX8360QDXFQNG author urn:uuid:a622022a-8834-4fbe-afc5-cb0076e27e76.
- 01GKVJ99HHQBAAX8360QDXFQNG author urn:uuid:f7e37ca9-5d53-4d62-b9cf-fd3ff239e4ae.
- 01GKVJ99HHQBAAX8360QDXFQNG dateCreated "2022-12-09T13:48:05Z".
- 01GKVJ99HHQBAAX8360QDXFQNG dateModified "2024-07-09T10:20:50Z".
- 01GKVJ99HHQBAAX8360QDXFQNG name "Long-term survey and characterization of cyflumetofen resistance in Tetranychus urticae populations from Turkey".
- 01GKVJ99HHQBAAX8360QDXFQNG pagination urn:uuid:552b97dc-5c9f-4bd2-a543-9a152e1d205d.
- 01GKVJ99HHQBAAX8360QDXFQNG sameAs LU-01GKVJ99HHQBAAX8360QDXFQNG.
- 01GKVJ99HHQBAAX8360QDXFQNG sourceOrganization urn:uuid:044666d2-2236-42e3-b358-fdecb9b73d8a.
- 01GKVJ99HHQBAAX8360QDXFQNG type A1.